Clinical Trial Update: A One-Year, Randomized, Double-Blind, Placebo-Controlled Trial of Rosiglitazone in Non-Alcoholic Steatohepatitis [Phase 2]

View source ↗

Summary

This document notes the completion of a Phase 2 randomized, double-blind, placebo-controlled trial evaluating rosiglitazone for non-alcoholic steatohepatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Steatohepatitis

Drugs mentioned

• Rosiglitazone (rosiglitazone)

Snippet

Sponsor: Association pour la Recherche sur les Maladies Hépatiques Virales | Conditions: Non Alcoholic Steatohepatitis | Phase 2 | Status: COMPLETED